Can-Fite Biopharma (CANF) Free Cash Flow (2010 - 2025)
Can-Fite Biopharma (CANF) free cash flow from Dec 31, 2010 to Jun 30, 2025. The TTM Can-Fite Biopharma (CANF) free cash flow is -$8.36M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Can-Fite Biopharma (CANF) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +35.93% |
| 3 Years TTM | -6.87% |
| 5 Years TTM | +4.31% |
| 10 Years TTM | +9.71% |
| All Time TTM | +3.14% |
Annual Free Cash Flow change of Can-Fite Biopharma (CANF)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$9.02M | +17.91% |
| 2024 | -$7.65M | -9.36% |
| 2023 | -$8.44M | -21.92% |
| 2022 | -$11M | +9.52% |
| 2021 | -$9.87M | -18.36% |
| 2020 | -$12M | +11.63% |
| 2019 | -$11M | +159.09% |
| 2018 | -$4.18M | -56.14% |
| 2017 | -$9.53M | +6.60% |
| 2016 | -$8.94M | +90.21% |
| 2015 | -$4.70M | -35.97% |
| 2014 | -$7.34M | -15.05% |
| 2013 | -$8.64M | +98.62% |
| 2012 | -$4.35M | -21.20% |
| 2011 | -$5.52M | +50.00% |
| 2010 | -$3.68M | N/A |
Comparison Can-Fite Biopharma (CANF) five years free cash flow CAGR with competitors
Can-Fite Biopharma (CANF) five years free cash flow CAGR is 4.28%.